Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 21% ± 8% | |
classical monocyte | 3 studies | 19% ± 3% | |
ciliated cell | 3 studies | 22% ± 4% | |
dendritic cell | 3 studies | 22% ± 2% |
Insufficient scRNA-seq data for expression of ACOT8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 807.51 | 1445 / 1445 | 100% | 11.71 | 183 / 183 |
liver | 100% | 734.65 | 226 / 226 | 100% | 11.79 | 406 / 406 |
ovary | 100% | 807.91 | 180 / 180 | 100% | 21.11 | 430 / 430 |
prostate | 100% | 985.29 | 245 / 245 | 100% | 18.43 | 502 / 502 |
stomach | 100% | 919.28 | 359 / 359 | 100% | 20.98 | 286 / 286 |
brain | 100% | 1325.81 | 2641 / 2642 | 100% | 18.79 | 705 / 705 |
skin | 100% | 1025.60 | 1808 / 1809 | 100% | 15.27 | 472 / 472 |
breast | 100% | 670.87 | 459 / 459 | 100% | 12.51 | 1117 / 1118 |
uterus | 100% | 765.07 | 170 / 170 | 100% | 15.85 | 458 / 459 |
pancreas | 100% | 461.54 | 327 / 328 | 100% | 12.84 | 178 / 178 |
thymus | 100% | 879.85 | 653 / 653 | 100% | 13.61 | 603 / 605 |
lung | 100% | 764.38 | 576 / 578 | 100% | 13.85 | 1155 / 1155 |
intestine | 100% | 976.18 | 966 / 966 | 100% | 20.69 | 525 / 527 |
bladder | 100% | 817.24 | 21 / 21 | 100% | 17.08 | 502 / 504 |
kidney | 100% | 1039.91 | 89 / 89 | 99% | 10.90 | 896 / 901 |
adrenal gland | 100% | 1732.62 | 258 / 258 | 99% | 15.83 | 228 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.06 | 29 / 29 |
spleen | 100% | 899.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.61 | 1 / 1 |
adipose | 100% | 632.96 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 918.60 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 664.63 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 9.48 | 79 / 80 |
heart | 98% | 883.34 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 920.19 | 908 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043649 | Biological process | dicarboxylic acid catabolic process |
GO_0006637 | Biological process | acyl-CoA metabolic process |
GO_0009062 | Biological process | fatty acid catabolic process |
GO_0036109 | Biological process | alpha-linolenic acid metabolic process |
GO_0016559 | Biological process | peroxisome fission |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0045225 | Biological process | negative regulation of CD4 production |
GO_0033540 | Biological process | fatty acid beta-oxidation using acyl-CoA oxidase |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0052816 | Molecular function | long-chain fatty acyl-CoA hydrolase activity |
GO_0052689 | Molecular function | carboxylic ester hydrolase activity |
GO_0004778 | Molecular function | succinyl-CoA hydrolase activity |
GO_0047603 | Molecular function | acetoacetyl-CoA hydrolase activity |
GO_0047994 | Molecular function | hydroxymethylglutaryl-CoA hydrolase activity |
GO_0052815 | Molecular function | medium-chain fatty acyl-CoA hydrolase activity |
GO_0016289 | Molecular function | acyl-CoA hydrolase activity |
GO_0047617 | Molecular function | fatty acyl-CoA hydrolase activity |
GO_0033882 | Molecular function | choloyl-CoA hydrolase activity |
GO_0003986 | Molecular function | acetyl-CoA hydrolase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ACOT8 |
Protein name | Acyl-coenzyme A thioesterase 8 (Acyl-CoA thioesterase 8) (EC 3.1.2.1) (EC 3.1.2.11) (EC 3.1.2.2) (EC 3.1.2.3) (EC 3.1.2.5) (Choloyl-coenzyme A thioesterase) (EC 3.1.2.27) (HIV-Nef-associated acyl-CoA thioesterase) (Peroxisomal acyl-CoA thioesterase 2) (PTE-2) (Peroxisomal acyl-coenzyme A thioester hydrolase 1) (PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1) (Thioesterase II) (hACTE-III) (hACTEIII) (hTE) palmitoyl-CoA hydrolase (EC 3.1.2.2) Acyl-CoA thioesterase 8 |
Synonyms | PTE1 ACTEIII |
Description | FUNCTION: Catalyzes the hydrolysis of acyl-CoAs into free fatty acids and coenzyme A (CoASH), regulating their respective intracellular levels . Displays no strong substrate specificity with respect to the carboxylic acid moiety of Acyl-CoAs (By similarity). Hydrolyzes medium length (C2 to C20) straight-chain, saturated and unsaturated acyl-CoAS but is inactive towards substrates with longer aliphatic chains . Moreover, it catalyzes the hydrolysis of CoA esters of bile acids, such as choloyl-CoA and chenodeoxycholoyl-CoA and competes with bile acid CoA:amino acid N-acyltransferase (BAAT) (By similarity). Is also able to hydrolyze CoA esters of dicarboxylic acids (By similarity). It is involved in the metabolic regulation of peroxisome proliferation . .; FUNCTION: (Microbial infection) May mediate Nef-induced down-regulation of CD4 cell-surface expression . . |
Accessions | E9PJN0 ENST00000457981.5 O14734 ENST00000652771.1 ENST00000461272.5 E9PIS4 ENST00000487205.5 H7C5A7 ENST00000426915.1 ENST00000483141.1 E9PRD4 A0A494C0N6 F6VBM3 ENST00000488679.5 Q9BR14 H0Y698 ENST00000486165.5 ENST00000217455.9 |